Adsorption av Low Density Lipoprotein (LDL) till modifierade agaros matriser

  • Negin Khandan

    Student thesis: University Diploma


    Individuals that suffer from homozygote Familiar Hyperkolesterolemia (FH), has increased amounts of Low Density Lipoproteins (LDL) which leads to a higher risk of cardiovascular diseases. Treatment of these individuals can be achieved by extracorporeal elimination of LDL using specific columns. The aim of this study was to evaluate different agarose-modified adsorbents ability to adsorb LDL from human plasma. The adsorbents (DALI, Zetarose, sulphonated Zetarose and taurine immobilized onto Zetarose) were incubated for 60 minutes with human plasma diluted with PBS, in a ratio of 1:5 between the matrix and the plasma during rotation with a rotator. After incubation the samples were centrifuged and the LDL content was determined in both the supernatant and the pellet. The amount proteins adsorbed were assayed by eluting the pellets. LDL was determined indirectly using Friedwalds equation; LDL= Total cholesterol (TC) - High density lipoprotein (HDL)-(0,45x Triglycerides (TG). The values of TC and TG in the sample were determined enzymatically, whilst HDL was quantified as TC after LDL-precipitation by dextran sulfate. The results clearly show that DALI has good adsorption capacity, but none of the modified Zetaroses shows any capacity to absorb LDL from human plasma. Desorption of the adsorbents using SDS gave higher amounts of eluated protein compared to NaCl elution, indicating hydrofobic proteins. However, the methods used in this study could be used to evaluate new adsorbents for LDL-elimination applications in patients with chronic hyperlipemia.

    Date of Award2016-Apr-26
    Original languageSwedish
    SupervisorLennart Ljunggren (Supervisor) & Ann-Sofi Rehnstam-Holm (Examiner)

    Educational program

    • Bachelor of Science in Biomedical Laboratory Science

    University credits

    • 15 HE credits

    Swedish Standard Keywords

    • Biomedical Laboratory Science/Technology (30402)


    • low-density lipoprotein
    • apolipoprotein b-100
    • familial hypercholesterolemia
    • ldl apheresis
    • cardiovascular diseases
    • modified agarose matrices

    Cite this